DAVITA INC. (DVA)
Health Care / Health Care Services
S&P 500$194.08
Above average across most dimensions. A solid candidate.
Strong Buy
Score based on 5 of 5 models — high confidence
Is DAVITA INC. a Good Investment in 2026?
DAVITA INC. (DVA) scores 7.6 out of 10 on AlphaStocks' composite model, earning a Strong Buy rating. The Greenblatt Magic Formula model rates DAVITA INC. as Strong (Top 25% (rank 17%)). The Lynch model is the least favorable, rating it Neutral. DAVITA INC. ranks #20 out of 1126 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Trades at 14x earnings — near sector median of 26x.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
6/9
Buffett
Attractive
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Neutral
PEG 1.3 · Stalwart
Greenblatt
Strong
Top 25% (rank 17%)
Frequently Asked Questions
Is DAVITA INC. (DVA) a good investment?
What is DAVITA INC.'s Piotroski F-Score?
Is DVA overvalued or undervalued?
How does DVA compare to other Health Care stocks?
What do investment models say about DVA?
Similar Stocks
Compare DVA with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer